Factory Mutual Insurance Co. increased its position in shares of Medtronic PLC (NYSE:MDT) by 3.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,068,720 shares of the medical technology company’s stock after acquiring an additional 40,000 shares during the period. Factory Mutual Insurance Co. owned approximately 0.08% of Medtronic PLC worth $94,850,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Jackson Grant Investment Advisers Inc. increased its holdings in shares of Medtronic PLC by 0.3% in the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 2,920 shares of the medical technology company’s stock worth $235,000 after buying an additional 9 shares during the last quarter. Hudock Capital Group LLC increased its holdings in shares of Medtronic PLC by 0.6% in the 1st quarter. Hudock Capital Group LLC now owns 2,184 shares of the medical technology company’s stock worth $175,000 after buying an additional 12 shares during the last quarter. Triangle Securities Wealth Management increased its holdings in shares of Medtronic PLC by 0.3% in the 2nd quarter. Triangle Securities Wealth Management now owns 4,396 shares of the medical technology company’s stock worth $390,000 after buying an additional 15 shares during the last quarter. Tarbox Group Inc. increased its holdings in shares of Medtronic PLC by 0.4% in the 1st quarter. Tarbox Group Inc. now owns 5,180 shares of the medical technology company’s stock worth $417,000 after buying an additional 20 shares during the last quarter. Finally, Shufro Rose & Co. LLC increased its holdings in shares of Medtronic PLC by 0.3% in the 1st quarter. Shufro Rose & Co. LLC now owns 10,381 shares of the medical technology company’s stock worth $836,000 after buying an additional 28 shares during the last quarter. 80.75% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Factory Mutual Insurance Co. Has $94.85 Million Position in Medtronic PLC (MDT)” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.dailypolitical.com/2017/09/13/factory-mutual-insurance-co-has-94-85-million-position-in-medtronic-plc-mdt.html.

In other Medtronic PLC news, Director Richard H. Anderson acquired 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, June 21st. The stock was purchased at an average cost of $88.90 per share, with a total value of $497,840.00. Following the transaction, the director now owns 71,910 shares of the company’s stock, valued at $6,392,799. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Bryan C. Hanson sold 12,000 shares of the firm’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $88.57, for a total value of $1,062,840.00. The disclosure for this sale can be found here. 0.31% of the stock is owned by company insiders.

Medtronic PLC (NYSE:MDT) traded down 0.577% on Wednesday, reaching $81.825. 1,791,781 shares of the company’s stock were exchanged. The firm has a market cap of $110.84 billion, a PE ratio of 27.541 and a beta of 1.03. The firm has a 50 day moving average price of $82.48 and a 200 day moving average price of $83.66. Medtronic PLC has a one year low of $69.35 and a one year high of $89.72.

Medtronic PLC (NYSE:MDT) last issued its earnings results on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.04. Medtronic PLC had a return on equity of 12.92% and a net margin of 13.75%. The business had revenue of $7.39 billion during the quarter, compared to the consensus estimate of $7.44 billion. During the same period last year, the company earned $1.03 EPS. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. On average, equities analysts anticipate that Medtronic PLC will post $4.77 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 29th will be paid a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend is Thursday, September 28th. Medtronic PLC’s dividend payout ratio (DPR) is presently 61.95%.

Several research firms recently commented on MDT. Goldman Sachs Group, Inc. (The) began coverage on shares of Medtronic PLC in a report on Tuesday, May 16th. They set a “neutral” rating and a $87.00 target price on the stock. Zacks Investment Research lowered shares of Medtronic PLC from a “hold” rating to a “sell” rating in a report on Tuesday, May 23rd. Evercore ISI reissued an “outperform” rating and set a $91.00 price target (up previously from $88.50) on shares of Medtronic PLC in a research report on Sunday, May 28th. BMO Capital Markets increased their price target on shares of Medtronic PLC from $87.00 to $94.00 and gave the company an “outperform” rating in a research report on Tuesday, May 30th. Finally, Morgan Stanley increased their price target on shares of Medtronic PLC from $84.00 to $86.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 30th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $88.78.

Medtronic PLC Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.